Detalhe da pesquisa
1.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695874
2.
Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia.
Ann Hematol
; 92(5): 653-60, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23340738
3.
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Lancet Oncol
; 9(2): 105-16, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18226581
4.
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
J Antimicrob Chemother
; 61(4): 939-46, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18272515
5.
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
J Clin Oncol
; 23(9): 1984-92, 2005 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15668467
6.
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
J Clin Oncol
; 21(2): 256-65, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12525517
7.
Treatment of older patients with AML.
Crit Rev Oncol Hematol
; 56(2): 247-59, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16246568
8.
Acute myeloid leukemia: treatment over 60.
Rev Clin Exp Hematol
; 6(1): 46-59; discussion 86-7, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060483
9.
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
Blood
; 111(2): 558-65, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17962512
10.
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood
; 109(11): 4686-92, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17317858
11.
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
J Clin Oncol
; 24(16): 2480-9, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16735702
12.
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood
; 106(12): 3725-32, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16123223
13.
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Blood
; 104(3): 634-41, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15016643